ConductScience.org, home

Paper42881185PubMed

Next-generation natural killer cell therapy: bench to bedside and beyond.

Zhao A and 9 others. Signal Transduct Target Ther, 2026.

Cite this record

ConductScience Library. Next-generation natural killer cell therapy: bench to bedside and beyond. Papers, record 42881185. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42881185

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Next-generation natural killer cell therapy: bench to bedside and beyond.
Journal
Signal Transduct Target Ther
Year
2026
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
Revised in PubMed
2026-10-20

Source PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhao AAiqi
2Xu JJing
3Deng WWenhai
4Zhang MMinghuan
5Shao YYanping
6Liu YYuhttps://orcid.org/0000-0002-1193-7830
7Liang AAibinhttps://orcid.org/0000-0002-8978-1987
8Wang XXiaobing
9Niu TTinghttps://orcid.org/0000-0003-1580-1014
10Qian WWenbinhttps://orcid.org/0000-0002-9817-6674

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Killer Cells, NaturalMajor topic
NeoplasmsMajor topic
Receptors, Chimeric AntigenMajor topic
Immunotherapy, AdoptiveMajor topic
Humans
Animals

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
LTGY24H080001Natural Science Foundation of Zhejiang Province (Zhejiang Provincial Natural Science Foundation)PubMed

Source PubMed

Download CSV of grants

References462

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120444980Rapid lytic granule convergence to the MTOC in natural killer cells is dependent on dynein but not cytolytic commitment.Mol Biol Cell2010https://conductscience.org/library/papers/20444980PubMed
227775550MicroRNA-29b mediates altered innate immune development in acute leukemia.J Clin Invest2016https://conductscience.org/library/papers/27775550PubMed
337391486Inserting EF1α-driven CD7-specific CAR at CD7 locus reduces fratricide and enhances tumor rejection.Leukemia2023https://conductscience.org/library/papers/37391486PubMed
422493516Proinflammatory cytokine signaling required for the generation of natural killer cell memory.J Exp Med2012https://conductscience.org/library/papers/22493516PubMed
537828009Perinatal murine cytomegalovirus infection reshapes the transcriptional profile and functionality of NK cells.Nat Commun2023https://conductscience.org/library/papers/37828009PubMed
635027451PDGF-D-PDGFRβ signaling enhances IL-15-mediated human natural killer cell survival.Proc Natl Acad Sci U S A2022https://conductscience.org/library/papers/35027451PubMed
7259390634-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors.Nat Med2015https://conductscience.org/library/papers/25939063PubMed
832826231Multidimensional Analyses of Donor Memory-Like NK Cells Reveal New Associations with Response after Adoptive Immunotherapy for Leukemia.Cancer Discov2020https://conductscience.org/library/papers/32826231PubMed
938238616Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial.Nat Med2024https://conductscience.org/library/papers/38238616PubMed
1040119192Enhancing human NK cell antitumor function by knocking out SMAD4 to counteract TGFβ and activin A suppression.Nat Immunol2025https://conductscience.org/library/papers/40119192PubMed
1117320507Chromatin modifications and their function.Cell2007https://conductscience.org/library/papers/17320507PubMed
1237074304Deficits in our understanding of natural killer cell development in mouse and human.Curr Opin Hematol2023https://conductscience.org/library/papers/37074304PubMed
1321173117Natural killer-cell differentiation by myeloid progenitors.Blood2011https://conductscience.org/library/papers/21173117PubMed
1437117524Senolytic vaccination improves normal and pathological age-related phenotypes and increases lifespan in progeroid mice.Nat Aging2021https://conductscience.org/library/papers/37117524PubMed
1530082830Epigenetic control of innate and adaptive immune memory.Nat Immunol2018https://conductscience.org/library/papers/30082830PubMed
1626873994Metabolic Reprogramming Supports IFN-γ Production by CD56bright NK Cells.J Immunol2016https://conductscience.org/library/papers/26873994PubMed
1718097043Lineage-specific transition of histone signatures in the killer cell Ig-like receptor locus from hematopoietic progenitor to NK cells.J Immunol2008https://conductscience.org/library/papers/18097043PubMed
1838890285The miR-29 family facilitates the activation of NK-cell immune responses by targeting the B7-H3 immune checkpoint in neuroblastoma.Cell Death Dis2024https://conductscience.org/library/papers/38890285PubMed
1936706761Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance.Cancer Cell2023https://conductscience.org/library/papers/36706761PubMed
2026697006Natural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer Immunotherapy.Front Immunol2015https://conductscience.org/library/papers/26697006PubMed

See all 462 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42881185

GET https://conductscience.org/api/papers/v1/42881185/references?page=2